Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TANGO THERAPEUTICS, INC.

(TNGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

BCTG Acquisition Corp.(NasdaqCM:BCTG) dropped from NASDAQ Composite Index

08/10/2021 | 12:00am EDT

BCTG Acquisition Corp. has been removed from NASDAQ Composite Index .


ę S&P Capital IQ 2021
All news about TANGO THERAPEUTICS, INC.
09/30TANGO THERAPEUTICS : Announces Presentation of Preclinical Data on Lead Program and Discov..
BU
09/20TANGO THERAPEUTICS : SVB Leerink Initiates Coverage on Tango Therapeutics With Outperform ..
MT
09/20TANGO THERAPEUTICS, INC.(NASDAQCM : TNGX) added to S&P TMI Index
CI
09/07TANGO THERAPEUTICS : Guggenheim Starts Tango Therapeutics at Buy with $16 Price Target
MT
09/07TANGO THERAPEUTICS : Barclays Initiates Tango Therapeutics With Overweight Rating, $18 Pri..
MT
09/07TANGO THERAPEUTICS : Wedbush Initiates Tango Therapeutics With Outperform Rating, $20 Pric..
MT
09/07TANGO THERAPEUTICS : Goldman Sachs Initiates Tango Therapeutics With Buy Rating, $17 Price..
MT
08/13TANGO THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acqui..
AQ
08/10BCTG ACQUISITION : Tango Therapeutics Debuts as Publicly Traded Precision Oncology Company..
AQ
08/10Tango Therapeutics, Inc. completed the acquisition of BCTG Acquisition Corp. from Boxer..
CI
More news
Analyst Recommendations on TANGO THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 37,5 M - -
Net income 2021 -59,1 M - -
Net cash 2021 324 M - -
P/E ratio 2021 -11,2x
Yield 2021 -
Capitalization 1 333 M 1 333 M -
EV / Sales 2021 26,9x
EV / Sales 2022 53,7x
Nbr of Employees 77
Free-Float 84,5%
Chart TANGO THERAPEUTICS, INC.
Duration : Period :
Tango Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TANGO THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 14,03 $
Average target price 19,20 $
Spread / Average Target 36,8%
EPS Revisions
Managers and Directors
Barbara L. Weber President, Chief Executive Officer & Director
Daniella Beckman Chief Financial Officer
Alan Huang Chief Scientific Officer
Alexis A. Borisy Independent Director
Aaron I. Davis Independent Director
Sector and Competitors
1st jan.Capi. (M$)
TANGO THERAPEUTICS, INC.22.64%1 333
MODERNA, INC.210.34%130 866
LONZA GROUP AG26.90%58 060
IQVIA HOLDINGS INC.38.89%47 683
SEAGEN INC.-1.38%31 426
CELLTRION, INC.-38.72%25 414